SAREPTA THERAPEUTICS, INC. Contractual Obligation, to be Paid, Year One
SAREPTA THERAPEUTICS, INC. (SRPT) had Contractual Obligation, to be Paid, Year One of $139.02 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInNextTwelveMonths · last filed 2026-08-05
- 2026-06-30: Contractual Obligation, to be Paid, Year One $139.02M.
- 2026-03-31: Contractual Obligation, to be Paid, Year One $120.53M.
- 2025-12-31: Contractual Obligation, to be Paid, Year One $507.44M.
- 2025-09-30: Contractual Obligation, to be Paid, Year One $284.53M.
| Period end | Contractual Obligation, to be Paid, Year One |
|---|---|
| 2026-06-30 | $139.02M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $120.53M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $507.44M 10-K · filed 2026-03-02 |
| 2025-09-30 | $284.53M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $320.56M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $168.17M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $943.07M 10-K · filed 2025-02-28 |
| 2024-09-30 | $312.34M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $230.76M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $165.29M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $1.03B 10-K · filed 2024-02-28 |
| 2023-09-30 | $762.24M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $416.33M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $375.18M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $649.64M 10-K · filed 2023-02-28 |
| 2021-12-31 | $647.12M 10-K · filed 2022-03-01 |
| 2020-12-31 | $632.26M 10-K · filed 2021-03-01 |
| 2019-12-31 | $378.74M 10-K · filed 2020-02-26 |
| 2018-12-31 | $182.35M 10-K · filed 2019-02-28 |
| 2017-12-31 | $81.68M 10-K · filed 2018-03-01 |
| 2016-12-31 | $47.21M 10-K · filed 2017-02-28 |
| 2015-12-31 | $60.44M 10-K · filed 2016-02-25 |
| 2014-12-31 | $56.23M 10-K · filed 2015-02-26 |
| 2014-06-30 | $42.78M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $44.90M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $55.64M 10-K · filed 2014-03-03 |
| 2012-12-31 | $2.10M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |